Skip to main content
Clinical Trials/ACTRN12614000849695
ACTRN12614000849695Completed未知

Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin in Patients with Colorectal Cancer

Goztepe Education and Research Hospital0 sites80 target enrollmentStarted: August 8, 2014Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Diagnosis
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • Patients with colorectal carsinoma
  • Patients with colorectal polyps without carcinoma
  • Control group (patients whose colonoscopy examinations revealed no pathology named as control group)

Exclusion Criteria

  • Active infection
  • Renal failure
  • Other organs cancer
  • Detection of less than 12 lymph nodes
  • Patients treated with neoadjuvant chemotherapy
  • Blood samples with hemolysis

Investigators

Sponsor
Goztepe Education and Research Hospital

Similar Trials